Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study

Fig. 2

The relative concentration of the signature VOCs between different groups. a The relative concentration of the 9 VOCs between COPD group and healthy controls. b The relative concentration of the 9 VOCs between PRISm group and healthy controls. c The relative concentration of the 3 VOCs between mild/moderate COPD group and severe/extremely severe COPD group. d The relative concentration of the 7 VOCs between asthma group and PRISm group. e The relative concentration of the 6 VOCs between asthma group and COPD group. f The relative concentration of the 5 VOCs between asthma group and healthy controls

Back to article page